Tag

Kwality Pharmaceuticals Limited

2 articles

Kwality Pharmaceuticals FY26 Revenue Up 36% to ₹503 Crore

Kwality Pharmaceuticals reported audited FY26 results with revenue of ₹503 crore, up 36% YoY, and PAT of ₹67.35 crore, up 69% YoY. EBITDA margins expanded 200 bps to 24% driven by improved product mix

Kwality Pharma Q4 FY26 Investor Conference Call

Kwality Pharmaceuticals schedules analyst call to discuss Q4 FY26 financial results on May 19, 2026. Conference call hosted by Go India Advisors pursuant to SEBI Listing Regulations disclosure require